Jupiter Neurosciences Files S-1/A Amendment

TL;DR

Jupiter Neurosciences filed an S-1/A, looks like they're gearing up for something big.

AI Summary

Jupiter Neurosciences, Inc. filed a Pre-Effective Amendment No. 21 to its Form S-1 Registration Statement on September 13, 2024. The company, formerly known as Jupiter Orphan Therapeutics, Inc. until July 13, 2016, is incorporated in Delaware and operates in the Pharmaceutical Preparations sector. Its principal executive offices are located in Jupiter, Florida.

Why It Matters

This filing indicates Jupiter Neurosciences is moving forward with its registration process, potentially paving the way for a future public offering or other significant corporate actions.

Risk Assessment

Risk Level: medium — S-1/A filings are typically associated with upcoming public offerings, which inherently carry market and execution risks.

Key Numbers

• 333-260183 — SEC File Number (Identifies the specific registration filing)
• 0001679628 — Central Index Key (Unique identifier for the company in SEC filings)

Key Players & Entities

• JUPITER NEUROSCIENCES, INC. (company) — Registrant
• Jupiter Orphan Therapeutics, Inc. (company) — Former company name
• 20160713 (date) — Date of name change
• 20240913 (date) — Filing date
• Christer Rosén (person) — Chief Executive Officer
• Delaware (jurisdiction) — State of incorporation
• Jupiter, Florida (location) — Principal executive offices location

FAQ

From the Filing

0001493152-24-036247.txt : 20240913 0001493152-24-036247.hdr.sgml : 20240913 20240913173012 ACCESSION NUMBER: 0001493152-24-036247 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 31 FILED AS OF DATE: 20240913 DATE AS OF CHANGE: 20240913 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JUPITER NEUROSCIENCES, INC. CENTRAL INDEX KEY: 0001679628 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474828381 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-260183 FILM NUMBER: 241298801 BUSINESS ADDRESS: STREET 1: 1001 NORTH US HWY 1 STREET 2: SUITE 504 CITY: JUPITER STATE: FL ZIP: 33477 BUSINESS PHONE: (561) 406-6154 MAIL ADDRESS: STREET 1: 1001 NORTH US HWY 1 STREET 2: SUITE 504 CITY: JUPITER STATE: FL ZIP: 33477 FORMER COMPANY: FORMER CONFORMED NAME: Jupiter Orphan Therapeutics, Inc. DATE OF NAME CHANGE: 20160713 S-1/A 1 forms-1a.htm As filed with the U.S. Securities and Exchange Commission on September 13, 2024 Registration No. 333-260183 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 PRE-EFFECTIVE AMENDMENT NO. 21 TO Form S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 JUPITER NEUROSCIENCES, INC. (Exact name of registrant as specified in its charter) Delaware 2834 47-4828381 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) Jupiter Neurosciences, Inc. 1001 North US HWY 1, Suite 504 Jupiter, Florida 33477 Telephone: (561) 406-6154 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Christer Rosén Chief Executive Officer Jupiter Neurosciences, Inc. 1001 North US HWY 1, Suite 504 Jupiter, Florida 33477 Telephone: (561) 406-6154 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: Laura Anthony, Esq. Craig D. Linder, Esq. Anthony, Linder & Cacomanolis, PLLC 1700 Palm Beach Lakes Blvd., Suite 820 West Palm Beach, Florida 33401 Telephone: (561) 514-0936 Facsimile: (561) 514-0832 Ralph De Martino, Esq. Cavas Pavri, Esq. ArentFox Schiff LLP 1717 K Street NW Washington, DC 20006 Telephone: (202) 857-6000 Facsimile: (202) 857-6395 Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. ☐ If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated fil